복강경 기기 시장 : 제품별, 사용별, 용도별, 최종사용자별 - 세계 예측(-2031년)

The global laparoscopic instrument market is projected to reach USD 15.86 billion by 2031 from USD 10.74 billion in 2026, at a CAGR of 8.1% during the forecast period.

Several key factors drive the growth of the laparoscopic instruments market. One of the main factors is the upward trend toward minimally invasive surgical procedures, favored for their benefits of smaller incisions, less postoperative pain, shorter duration of hospital stays, and faster patient recoveries. At the same time, the worldwide rise in the incidence rate of colorectal cancer, obesity, and gallbladder diseases requiring laparoscopic interventions also boosts the demand. Also, improvements in imaging, energy-based devices, and robotic assistance are contributing to the enhanced precision and better outcomes for laparoscopic surgeries. Increased healthcare spending, improved surgical infrastructure in developing countries, and the rise in awareness among patients and healthcare professionals are also huge contributors to the market expansion.

"By product, the laparoscopes segment is expected to account for the largest share in the laparoscopic instruments market."

The laparoscopes segment holds the largest share in the overall laparoscopic instruments market due to their crucial role in enabling clear visualization during minimally invasive procedures. Advanced, high-resolution laparoscopes are in high demand due to the growing use of laparoscopic procedures in a variety of specialties, including urology, gynecology, and general surgery. Wider use has been encouraged by innovations like flexible scopes, 3D visualization, HD and 4K imaging, and integrated camera systems, which have greatly improved surgical accuracy and patient outcomes. The market for this segment is further strengthened by the growing number of surgeries performed for chronic conditions and the regular requirement for healthcare facilities to replace or upgrade their imaging systems. They remain essential in contemporary surgical procedures due to their contribution to enhancing real-time visualization and diagnostic precision.

"By application, the general surgery segment is expected to have the largest market share in the laparoscopic instruments market."

General surgery leads the laparoscopic instruments market, largely due to the broad range of procedures such as hernia repairs, appendectomies, cholecystectomies, and bowel resections, which are increasingly performed through minimally invasive methods. The rising preference for laparoscopic techniques in general surgery is fueled by advantages like smaller incisions, less postoperative pain, quicker recovery, and shorter hospital stays. The global increase in gastrointestinal conditions, gallbladder issues, and abdominal infections has also driven up the number of general surgical interventions. Furthermore, advancements in laparoscopic technology, the growing pool of trained surgeons, and favorable reimbursement policies have supported wider adoption. The versatility and frequent use of laparoscopy in general surgery firmly establish it as a major driver of market growth.

"The US is projected to grow at the highest CAGR in the North America laparoscopic instruments market."

The US is anticipated to grow at the highest CAGR in the North American laparoscopic instruments market. The nation's sophisticated healthcare system, high rate of minimally invasive surgery adoption, and ongoing technological advancements are key factors in the market's growth. Laparoscopic procedures are becoming more common as a result of the rising prevalence of chronic diseases like obesity, colorectal cancer, and gastrointestinal disorders. Rapid product innovation and commercialization are also supported by significant R&D investments, the existence of significant medical device companies, and a supportive regulatory environment. Additionally, the United States enjoys the benefits of a well-established reimbursement system and a high degree of patient and healthcare professional awareness of the benefits of laparoscopic surgery.

A breakdown of the primary participants (supply-side) for the laparoscopic instruments market referred to in this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
• By Designation: C-level-45%, Director Level-35%, and Others-20%
• By Region: North America -27%, Europe -25%, Asia Pacific - 30%, Latin America - 8%, Middle East & Africa -10%

Prominent players in the laparoscopic instruments market are Olympus Corporation (Japan), Karl Storz SE & Co. KG (Germany), Johnson & Johnson (USA), Fujifilm Holdings Corporation (Japan), Medtronic plc (Ireland), Stryker Corporation (USA), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (USA), Smith & Nephew plc (UK), Hoya Corporation (Japan), Scholly Fiberoptic GmbH (Germany), Victor Medical Instruments Co., Ltd. (China), Emedomed Systems GmbH (Germany), Richard Wolf GmbH (Germany), CONMED Corporation (USA), Capsovision, Inc. (USA), The Cooper Companies Inc. (USA), Teleflex Incorporated (USA), Carl Zeiss AG (Germany), Anthrex, Inc. (USA), Laborie Medical Technologies, Inc. (Canada), Myolotec Inc. (USA), Geyi Medical Instrument Co., Ltd. (China), Fortimedix Surgical B.V. (Netherlands), and Dantschke Medizintechnik GmbH & Co. KG (Germany).

Research Coverage:

The report analyzes the laparoscopic instruments market and aims at estimating the market size and future growth potential of this market based on product, application, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall laparoscopic instruments market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report will also help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (Rising volume of minimally invasive surgeries (MIS), Adoption of single-use laparoscopes to prevent infectious disease, Rising prevalence of colorectal cancer), restraints (Unfavourable healthcare reforms in the US, Dearth of trained practitioners of laparoscopy, High capital investment and operational costs), opportunities (Expansion into emerging markets with growing healthcare infrastructure, Growing healthcare market in emerging economies) and challenges (Gaps in infrastructural support for laparoscopic procedures in developing countries, Regulatory hurdles and compliance complexity)
• Market Penetration: It includes extensive information on products offered by the major players in the global laparoscopic instruments market. The report includes segmentation of the market by product, application, end user, and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global laparoscopic instruments market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global laparoscopic instruments market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, product offerings, and capacities of the major competitors in the global laparoscopic instruments market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS CONSIDERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 LAPAROSCOPIC INSTRUMENTS MARKET OVERVIEW
• 3.2 ASIA PACIFIC: LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE AND COUNTRY (2025)
• 3.3 LAPAROSCOPIC INSTRUMENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES (2025)
• 3.4 LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION (2024-2031)
• 3.5 LAPAROSCOPIC INSTRUMENTS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
  • 4.1.1 DRIVERS
    • 4.1.1.1 Increasing adoption of minimally invasive surgeries over open surgeries
    • 4.1.1.2 Rising adoption of single-use laparoscopic instruments
    • 4.1.1.3 Growing prevalence of colorectal cancer
  • 4.1.2 RESTRAINTS
    • 4.1.2.1 Unfavorable healthcare reforms
    • 4.1.2.2 Dearth of trained professionals
  • 4.1.3 OPPORTUNITIES
    • 4.1.3.1 Improving healthcare markets in emerging economies
    • 4.1.3.2 Technological advancements and innovations in laparoscopic instruments
  • 4.1.4 CHALLENGES
    • 4.1.4.1 Regulatory hurdles and compliance complexity
• 4.2 UNMET NEEDS AND WHITE SPACES
  • 4.2.1 UNMET NEEDS IN LAPAROSCOPIC INSTRUMENTS MARKET
  • 4.2.2 WHITE SPACE OPPORTUNITIES
• 4.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.3.1 INTERCONNECTED MARKETS
  • 4.3.2 CROSS-SECTOR OPPORTUNITIES MARKET
• 4.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 THREAT OF SUBSTITUTES
  • 5.1.5 THREAT OF NEW ENTRANTS
• 5.2 MACROECONOMIC OUTLOOK
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS AND FORECAST
  • 5.2.3 TRENDS IN MINIMALLY INVASIVE SURGERY INDUSTRY
  • 5.2.4 TRENDS IN ENDOSCOPY EQUIPMENT INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE, BY KEY PLAYER (2025)
  • 5.6.2 AVERAGE SELLING PRICE TREND, BY REGION (2023-2025)
• 5.7 TRADE DATA ANALYSIS
  • 5.7.1 IMPORT DATA FOR LAPAROSCOPIC INSTRUMENTS PRODUCTS (HS CODE 901890)
  • 5.7.2 EXPORT DATA FOR LAPAROSCOPIC INSTRUMENT PRODUCTS (HS CODE 901890)
• 5.8 KEY CONFERENCES AND EVENTS, 2026-2027
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.10 INVESTMENT AND FUNDING SCENARIO
• 5.11 CASE STUDY ANALYSIS
  • 5.11.1 CASE STUDY 1: ETHICON'S ENSEAL X1 TISSUE SEALER TO TREAT UTERINE FIBROIDS
  • 5.11.2 CASE STUDY 2: AIR QUALITY IMPROVEMENTS IN LAPAROSCOPIC DISINFECTION UNITS WITH AIRSTERIL PHOTO-CATALYTIC AIR PURIFIERS
  • 5.11.3 CASE STUDY 3: UV-C DISINFECTION SYSTEMS IN OPERATING THEATERS TO REDUCE HOSPITAL-ACQUIRED INFECTIONS
• 5.12 IMPACT OF 2025 US TARIFFS-LAPAROSCOPIC INSTRUMENTS MARKET
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 PRICE IMPACT ANALYSIS
  • 5.12.4 IMPACT ON COUNTRIES/REGIONS
    • 5.12.4.1 US
    • 5.12.4.2 Europe
    • 5.12.4.3 Asia Pacific
  • 5.12.5 IMPACT ON END-USER INDUSTRIES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 HIGH-DEFINITION AND 4K IMAGING SYSTEMS
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 SURGICAL NAVIGATION AND IMAGING SOFTWARE
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 ROBOTIC SURGICAL PLATFORMS
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.4.1 SHORT-TERM (2025-2027) PRODUCT REFINEMENT & COMMERCIAL EXPANSION
  • 6.4.2 MID-TERM (2027-2030) | FUNCTIONAL INTEGRATION & BROADER ADOPTION
  • 6.4.3 LONG-TERM (2030-2035+) | ADAPTIVE INSTRUMENTATION & SELECTIVE DISRUPTION
• 6.5 PATENT ANALYSIS
• 6.6 FUTURE APPLICATIONS OF LAPAROSCOPIC INSTRUMENTS
• 6.7 IMPACT OF AI/GEN AI ON LAPAROSCOPIC INSTRUMENTS MARKET
  • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
  • 6.7.2 BEST PRACTICES IN LAPAROSCOPIC INSTRUMENTS
  • 6.7.3 CASE STUDIES OF AI IMPLEMENTATION
  • 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
  • 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN LAPAROSCOPIC INSTRUMENTS MARKET

7 REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.1.1 North America: Regulatory Bodies, Government Agencies, and Other Organizations
    • 7.1.1.2 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
    • 7.1.1.3 Asia Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
  • 7.1.2 REGULATORY FRAMEWORK
    • 7.1.2.1 North America
      • 7.1.2.1.1 US
      • 7.1.2.1.2 Canada
    • 7.1.2.2 Europe
    • 7.1.2.3 Asia Pacific
      • 7.1.2.3.1 Japan
      • 7.1.2.3.2 China
      • 7.1.2.3.3 India
    • 7.1.2.4 Latin America
    • 7.1.2.5 Middle East & Africa and GCC Countries
  • 7.1.3 INDUSTRY STANDARDS
• 7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
• 8.5 MARKET PROFITABILITY
  • 8.5.1 REVENUE POTENTIAL
  • 8.5.2 COST DYNAMICS
  • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 LAPAROSCOPIC INSTRUMENTS MARKET, BY PRODUCT

• 9.1 INTRODUCTION
• 9.2 LAPAROSCOPES
  • 9.2.1 VIDEO LAPAROSCOPES
    • 9.2.1.1 Delivery of brighter and higher-quality images of mucosal surface to propel adoption
  • 9.2.2 FIBER LAPAROSCOPES
    • 9.2.2.1 Affordability and operational simplicity to aid adoption in resource-limited environments and basic diagnostic procedures
• 9.3 ENERGY DEVICES
  • 9.3.1 INCREASING DEMAND FOR REUSABLE MONOPOLAR AND BIPOLAR COAGULATION ENERGY DEVICES TO BOOST MARKET GROWTH
• 9.4 CLOSURE DEVICES
  • 9.4.1 TECHNOLOGICAL ADVANCEMENTS AND PRODUCT INNOVATIONS TO FUEL MARKET GROWTH
• 9.5 HAND INSTRUMENTS
  • 9.5.1 RISING NUMBER OF GENERAL LAPAROSCOPIC SURGERIES TO FAVOR MARKET GROWTH
• 9.6 ACCESS DEVICES
  • 9.6.1 ACCESS DEVICES TO CREATE AND MAINTAIN PORTS OF ENTRY FOR OTHER INSTRUMENTS
• 9.7 ACCESSORIES
  • 9.7.1 INCREASING SURGICAL VOLUMES TO SUPPORT MARKET GROWTH
• 9.8 INSUFFLATORS
  • 9.8.1 RISING NUMBER OF LAPAROSCOPIC SURGERIES TO BOOST DEMAND FOR CO2 INSUFFLATORS
• 9.9 SUCTION/IRRIGATION SYSTEMS
  • 9.9.1 POPULARITY OF INTEGRATED FLUID MANAGEMENT SYSTEMS FOR LAPAROSCOPIC PROCEDURES TO DRIVE MARKET

10 LAPAROSCOPIC INSTRUMENTS MARKET, BY USAGE

• 10.1 INTRODUCTION
• 10.2 REUSABLE LAPAROSCOPIC INSTRUMENTS
  • 10.2.1 HIGH DURABILITY, COST-EFFECTIVENESS, AND BETTER COMPATIBILITY TO FUEL MARKET GROWTH
• 10.3 DISPOSABLE LAPAROSCOPIC INSTRUMENTS
  • 10.3.1 RISING EMPHASIS ON INFECTION PREVENTION AND INCREASING NUMBER OF OUTPATIENT PROCEDURES TO PROPEL MARKET

11 LAPAROSCOPIC INSTRUMENTS MARKET, BY APPLICATION

• 11.1 INTRODUCTION
• 11.2 GENERAL SURGERY
  • 11.2.1 PREFERENCE FOR LAPAROSCOPIC TECHNIQUES IS INCREASING FOR APPENDECTOMY, CHOLECYSTECTOMY, AND HERNIA REPAIR
• 11.3 GYNECOLOGICAL SURGERY
  • 11.3.1 INCREASING DEMAND FOR MINIMALLY INVASIVE GYNECOLOGICAL SURGERIES TO DRIVE MARKET
• 11.4 COLORECTAL SURGERY
  • 11.4.1 INCREASING INCIDENCE OF COLORECTAL CANCER TO AID MARKET GROWTH
• 11.5 BARIATRIC SURGERY
  • 11.5.1 GROWING PREVALENCE OF OBESITY TO AUGMENT MARKET GROWTH
• 11.6 UROLOGICAL SURGERY
  • 11.6.1 INCREASING INCIDENCE OF CHRONIC UROLOGICAL DISEASES TO DRIVE MARKET
• 11.7 PEDIATRIC SURGERY
  • 11.7.1 PREFERENCE FOR MINIMALLY INVASIVE TECHNIQUES IN TREATING CONGENITAL CONDITIONS IN CHILDREN TO BOOST MARKET GROWTH
• 11.8 OTHER APPLICATIONS

12 LAPAROSCOPIC INSTRUMENTS MARKET, BY END USER

• 12.1 INTRODUCTION
• 12.2 HOSPITALS & CLINICS
  • 12.2.1 HIGH INVESTMENTS FROM GOVERNMENT BODIES AND PRIVATE INVESTORS TO DRIVE MARKET
• 12.3 AMBULATORY SURGICAL CENTERS
  • 12.3.1 INCREASED ADOPTION OF OUTPATIENT SURGERIES TO BOOST MARKET GROWTH
• 12.4 OTHER END USERS

13 LAPAROSCOPIC INSTRUMENTS MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 US
    • 13.2.1.1 US to dominate global laparoscopic instruments market during forecast period
  • 13.2.2 CANADA
    • 13.2.2.1 Rising incidence of chronic diseases among geriatric population to fuel market growth
• 13.3 EUROPE
  • 13.3.1 GERMANY
    • 13.3.1.1 High incidence of cancer and stroke to propel market growth
  • 13.3.2 FRANCE
    • 13.3.2.1 Favorable health insurance system and increased adoption of minimally invasive surgical procedures to boost market growth
  • 13.3.3 UK
    • 13.3.3.1 Implementation of National Bowel Cancer Screening Programme by NHS to support adoption of laparoscopy
  • 13.3.4 ITALY
    • 13.3.4.1 Rising prevalence of colorectal cancer to boost market growth
  • 13.3.5 SPAIN
    • 13.3.5.1 Superior reimbursement scenario to augment market growth
  • 13.3.6 REST OF EUROPE
• 13.4 ASIA PACIFIC
  • 13.4.1 JAPAN
    • 13.4.1.1 Rapid growth in geriatric population and innovations in laparoscopic surgeries to fuel market growth
  • 13.4.2 CHINA
    • 13.4.2.1 Rising government healthcare spending to drive adoption of laparoscopic instruments
  • 13.4.3 INDIA
    • 13.4.3.1 Healthcare infrastructural improvements and implementation of favorable government initiatives to support market growth
  • 13.4.4 AUSTRALIA
    • 13.4.4.1 Increasing obesity rates and rising number of bariatric surgeries to aid market growth
  • 13.4.5 SOUTH KOREA
    • 13.4.5.1 High geriatric population and increased number of surgical procedures to propel market growth
  • 13.4.6 REST OF ASIA PACIFIC
• 13.5 LATIN AMERICA
  • 13.5.1 BRAZIL
    • 13.5.1.1 High demand for advanced surgical technologies to spur adoption of laparoscopic instruments
  • 13.5.2 MEXICO
    • 13.5.2.1 Increasing incidence of lifestyle-related disorders to augment market growth
  • 13.5.3 REST OF LATIN AMERICA
• 13.6 MIDDLE EAST & AFRICA
  • 13.6.1 GCC COUNTRIES
    • 13.6.1.1 Increasing incidence of lifestyle-related disorders and growing disposable income to favor market growth
  • 13.6.2 REST OF MIDDLE EAST & AFRICA

14 COMPETITIVE LANDSCAPE

• 14.1 INTRODUCTION
• 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LAPAROSCOPIC INSTRUMENTS MARKET
• 14.3 REVENUE ANALYSIS, 2021-2025
• 14.4 MARKET SHARE ANALYSIS, 2025
• 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 14.5.1 STARS
  • 14.5.2 EMERGING LEADERS
  • 14.5.3 PERVASIVE PLAYERS
  • 14.5.4 PARTICIPANTS
  • 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 14.5.5.1 Company footprint
    • 14.5.5.2 Region footprint
    • 14.5.5.3 Product footprint
    • 14.5.5.4 Usage footprint
    • 14.5.5.5 Application footprint
    • 14.5.5.6 End-user footprint
• 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 14.6.1 PROGRESSIVE COMPANIES
  • 14.6.2 DYNAMIC COMPANIES
  • 14.6.3 RESPONSIVE COMPANIES
  • 14.6.4 STARTING BLOCKS
  • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
• 14.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 14.7.1 FINANCIAL METRICS
  • 14.7.2 COMPANY VALUATION
  • 14.7.3 BRAND/PRODUCT COMPARISON
• 14.8 COMPETITIVE SCENARIO
  • 14.8.1 PRODUCT LAUNCHES & APPROVALS
  • 14.8.2 DEALS

15 COMPANY PROFILES

• 15.1 KEY PLAYERS
  • 15.1.1 JOHNSON & JOHNSON
    • 15.1.1.1 Business overview
    • 15.1.1.2 Products offered
    • 15.1.1.3 MnM view
      • 15.1.1.3.1 Right to win
      • 15.1.1.3.2 Strategic choices
      • 15.1.1.3.3 Weaknesses & competitive threats
  • 15.1.2 MEDTRONIC
    • 15.1.2.1 Business overview
    • 15.1.2.2 Products offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Product launches
      • 15.1.2.3.2 Deals
    • 15.1.2.4 MnM view
      • 15.1.2.4.1 Right to win
      • 15.1.2.4.2 Strategic choices
      • 15.1.2.4.3 Weaknesses & competitive threats
  • 15.1.3 STRYKER
    • 15.1.3.1 Business overview
    • 15.1.3.2 Products offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Product launches
      • 15.1.3.3.2 Deals
      • 15.1.3.3.3 Expansions
    • 15.1.3.4 MnM view
      • 15.1.3.4.1 Right to win
      • 15.1.3.4.2 Strategic choices
      • 15.1.3.4.3 Weaknesses & competitive threats
  • 15.1.4 OLYMPUS CORPORATION
    • 15.1.4.1 Business overview
    • 15.1.4.2 Products offered
    • 15.1.4.3 Recent developments
      • 15.1.4.3.1 Product launches
      • 15.1.4.3.2 Deals
    • 15.1.4.4 MnM view
      • 15.1.4.4.1 Right to win
      • 15.1.4.4.2 Strategic choices
      • 15.1.4.4.3 Weaknesses & competitive threats
  • 15.1.5 APPLIED MEDICAL
    • 15.1.5.1 Business overview
    • 15.1.5.2 Products offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Product launches & approvals
      • 15.1.5.3.2 Deals
    • 15.1.5.4 MnM view
      • 15.1.5.4.1 Right to win
      • 15.1.5.4.2 Strategic choices
      • 15.1.5.4.3 Weaknesses & competitive threats
  • 15.1.6 KARL STORZ SE & CO. KG
    • 15.1.6.1 Business overview
    • 15.1.6.2 Products offered
    • 15.1.6.3 Recent developments
      • 15.1.6.3.1 Deals
  • 15.1.7 FUJIFILM HOLDINGS CORPORATION
    • 15.1.7.1 Business overview
    • 15.1.7.2 Products offered
  • 15.1.8 HOYA CORPORATION
    • 15.1.8.1 Business overview
    • 15.1.8.2 Products offered
    • 15.1.8.3 Recent developments
      • 15.1.8.3.1 Deals
  • 15.1.9 CONMED CORPORATION
    • 15.1.9.1 Business overview
    • 15.1.9.2 Products offered
  • 15.1.10 COOK
    • 15.1.10.1 Business overview
    • 15.1.10.2 Products offered
  • 15.1.11 B. BRAUN SE
    • 15.1.11.1 Business overview
    • 15.1.11.2 Products offered
  • 15.1.12 VICTOR MEDICAL INSTRUMENTS CO., LTD.
    • 15.1.12.1 Business overview
    • 15.1.12.2 Products offered
  • 15.1.13 ENDOMED SYSTEMS GMBH
    • 15.1.13.1 Business overview
    • 15.1.13.2 Products offered
  • 15.1.14 SCHOLLY FIBEROPTIC GMBH
    • 15.1.14.1 Business overview
    • 15.1.14.2 Products offered
  • 15.1.15 BOSTON SCIENTIFIC CORPORATION
    • 15.1.15.1 Business overview
    • 15.1.15.2 Products offered
• 15.2 OTHER PLAYERS
  • 15.2.1 BOWA MEDICAL
  • 15.2.2 COOPER COMPANIES
  • 15.2.3 ERBE
  • 15.2.4 KANGJI MEDICAL
  • 15.2.5 MINDRAY
  • 15.2.6 TELEFLEX INCORPORATED
  • 15.2.7 FORTIMEDIX SURGICAL
  • 15.2.8 DANTSCHKE MEDIZINTECHNIK GMBH & CO. KG
  • 15.2.9 MYELOTEC, INC.
  • 15.2.10 RICHARD WOLF GMBH
  • 15.2.11 ZHEJIANG GEYI MEDICAL INSTRUMENT CO., LTD.

16 RESEARCH METHODOLOGY

• 16.1 RESEARCH DATA
  • 16.1.1 SECONDARY DATA
    • 16.1.1.1 Key data from secondary sources
  • 16.1.2 PRIMARY DATA
    • 16.1.2.1 Key data from primary sources
    • 16.1.2.2 Key industry insights
• 16.2 MARKET SIZE ESTIMATION
  • 16.2.1 BOTTOM-UP APPROACH
  • 16.2.2 TOP-DOWN APPROACH
  • 16.2.3 BASE NUMBER ESTIMATION
• 16.3 MARKET FORECAST APPROACH
• 16.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 16.5 ASSUMPTIONS
  • 16.5.1 MARKET SHARE ASSUMPTIONS
  • 16.5.2 RESEARCH ASSUMPTIONS
• 16.6 FACTOR ANALYSIS
• 16.7 RISK ASSESSMENT
• 16.8 METHODOLOGY-RELATED LIMITATIONS
  • 16.8.1 SCOPE-RELATED LIMITATIONS
  • 16.8.2 METHODOLOGY-RELATED LIMITATIONS

17 APPENDIX

• 17.1 DISCUSSION GUIDE
• 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 17.3 CUSTOMIZATION OPTIONS
• 17.4 RELATED REPORTS
• 17.5 AUTHOR DETAILS